explore -WSS

explore

author：comprehensive 2025-10-01 23:59:23 - browse：98

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Stories you might have missed in 2023: health, science, medicine

entertainment

WSS

STAT Virtual Event: JPM Recap, Live!

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

One Duchenne patient's bittersweet hope for new treatment

A preacher's new calling: Diversifying neuroscience research

Fauci's latest grilling in Congress: 9 hours, behind closed doors

focus

explore

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Allen Institute goes after foundational questions, CEO Costa says

Hepatitis C has a cure — but many Americans still lack access to it

A Greenpeace activist is fined for crash

BioMarin wins approval for gene therapy to treat hemophilia A

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Medical leaders decry Supreme Court decision on affirmative action

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

hotspot

Companies helping big Covid

Nonprofit, backed by Microsoft, to certify AI tools in health care

Study suggests new cause of Down syndrome: cells linked to aging

STAT Virtual Event: JPM Recap, Live!

Study suggests new cause of Down syndrome: cells linked to aging

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Wikipedia

leisure time

entertainment

Wikipedia